Eucerin Actinic Control MD SPF 100 – 80ml
Eucerin Actinic Control MD SPF 100 – A light topical medical device for the prevention of actinic keratosis and non-melanoma skin cancer or as adjunctive treatment of actinic keratosis. With SPF 100 it provides very high UVB and UVA protection.
It’s easy-to-apply, light fluid-texture is perfect for everyday use.
- Certified medical device with SPF 100 UVB and UVA protection
- Prevents actinic keratosis and non-melanoma skin cancer
- Light texture for everyday use
For the prevention of actinic keratosis and non-melanoma skin cancer Actinic Control MD SPF 100 is a certified medical device for the prevention of actinic keratosis and non-melanoma skin cancer. Furthermore, it serves as an adjunctive treatment for actinic keratosis.
UV-induced DNA damage to keratinocytes can cause actinic keratosis.
Actinic keratosis is the most common pre-cancer on the skin, potentially progressing into non-melanoma skin cancer (squamous cell carcinoma) if left untreated. But the right sun protection can make all the difference. The high effectiveness of Actinic Control MD comes from its high SPF 100.
The higher the SPF, the more UVB-rays are blocked out – which are a major cause of cell damage. The more UVB-rays are blocked out, the less cell damage the skin will accumulate during sun exposure.
An SPF 100 for example blocks out about 99% of UVB-rays. Additionally, the high SPF 100 can also compensate for sunscreen under-application. As a light textured fluid, it is suitable for everyday use, making it pleasant to apply, and easy for you to stay protected while enjoying everyday outdoor activities.
Sustainability & Environment –
- Free of Microplastics (according to UNEP definition)
- Foldingbox made of FSC certified paper
- UV Filter system without Octocrylene
Eucerin – 100 years of history and innovative science for high-quality skincare that works. To make you feel good and enjoy life to the fullest, discover the life-changing power of dermatological skincare.
Reviews
There are no reviews yet.